Changeflow GovPing Pharma & Drug Safety Integrated system for 3D tissue culture
Routine Notice Added Final

Integrated system for 3D tissue culture

Favicon for changeflow.com USPTO Patent Grants - Biotech (C12N)
Published
Detected
Email

Summary

The USPTO granted Patent US12595449B2 to VALO Health, Inc. covering an integrated system with embedded electrodes for growing, maintaining, and using 3D tissues in vitro. The patent includes 13 claims under CPC classifications C12M and C12N covering scalable, automated tissue stimulation devices and systems. The filing date was February 3, 2021, with Application No. 17798048.

What changed

The USPTO issued Patent US12595449B2 to VALO Health, Inc. for an integrated system enabling 3D tissue culture through embedded electrodes. The patent covers devices, apparatuses, and systems for scalable, automated tissue stimulation in vitro. The 8 named inventors include Roozbeh Aschar-Sobbi, Maw-Lin Kuo, Roger Stenerson, Winston Sun, and others. The patent provides intellectual property protection for tissue engineering technology spanning CPC codes in the C12M and C12N classifications.

This patent grant establishes VALO Health's proprietary rights in 3D tissue culture technology and may affect freedom-to-operate considerations for competitors developing similar electrode-based tissue stimulation systems. Companies in the biotechnology, pharmaceutical research, and medical device sectors developing 3D cell culture platforms should review the patent claims to assess potential licensing needs or design-around implications.

What to do next

  1. Monitor for updates

Archived snapshot

Apr 7, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Grants

Integrated system for 3D tissue culture

Grant US12595449B2 Kind: B2 Apr 07, 2026

Assignee

VALO HEALTH, INC.

Inventors

Roozbeh Aschar-Sobbi, Maw-Lin Kuo, Roger Stenerson, Winston Sun, Dickshitha Thyagharajon, Ya Kevin Thao, Chris Todd, Brian Wilfley

Abstract

Embodiments described herein relate generally to devices, apparatuses, and systems with embedded electrodes for growing, maintaining, and/or using 3D tissues in vitro. The devices, apparatuses, and systems described herein can provide scalable, automated tissue stimulation.

CPC Classifications

C12M 21/08 C12M 1/3446 C12M 23/12 C12M 35/02 C12M 41/48 C12M 41/40 C12N 2513/00 C12N 2533/40

Filing Date

2021-02-03

Application No.

17798048

Claims

13

View original document →

Named provisions

C12M 21/08 C12M 1/3446 C12M 23/12 C12M 35/02 C12M 41/48 C12M 41/40 C12N 2513/00 C12N 2533/40

Get daily alerts for USPTO Patent Grants - Biotech (C12N)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 7th, 2026
Instrument
Notice
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
US12595449B2

Who this affects

Applies to
Medical device makers Pharmaceutical companies Research institutions
Industry sector
3254.1 Biotechnology
Activity scope
3D tissue culture systems In vitro tissue stimulation Automated tissue engineering
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare Medical Devices

Get alerts for this source

We'll email you when USPTO Patent Grants - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!